UTHR

#531
United Therapeutics Corporation - Common Stock
557.7 5 USD
-0.77%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
556.00
563.04
Rango anual
272.17
609.35
Cambio diario
-0.77%
Variación mensual
-2.91%
Variación en los últimos 6 meses
+15.08%
Cambio anual
+74.20%
Cierres anteriores
562.0 9
Open
562.7 4
Mínimo
556.0 0
High
563.0 4
Volumen
159
Ver el calendario completo Full chart

Financials

Visión general Informes Estadísticas
Trimestre Año
  • Market Capitalization 23.67 B
  • Employee 1 400
  • Founded 1996
  • CEO N/A
  • Website www.unither.com
  • Headquarter Delaware, United States
  • FIGI BBG000BV4XJ1
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
17.49
Relación precio/flujo de caja
7.33

United Therapeutics Corporation - Common Stock

United Therapeutics Corporation is an American biotechnology company that develops pharmaceuticals and technologies related to organ transplantation, including xenotransplantation. Many of the company's products are focused towards lung disease and organ manufacturing. United Therapeutics is co-headquartered in Silver Spring, Maryland and Research Triangle Park, North Carolina, with additional facilities in Magog and Bromont, Quebec; Melbourne and Jacksonville, Florida; Blacksburg, Virginia; and Manchester, New Hampshire.

Noticias